Enhancing tuberculosis vaccine efficacy with a heterologous mRNA-ChAdOx1 prime-pull strategy targeting lung-resident memory T cells.
Saved in:
| Title: | Enhancing tuberculosis vaccine efficacy with a heterologous mRNA-ChAdOx1 prime-pull strategy targeting lung-resident memory T cells. |
|---|---|
| Authors: | Korompis M; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., De Voss CJ; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Li S; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Ateere A; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., McShane H; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Stylianou E; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Apr 20; Vol. 17, pp. 1807190. Date of Electronic Publication: 2026 Apr 20 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
